Merck, Upsher-Smith to pay $60 million in 'pay-for-delay' drug case

(Reuters) - Merck & Co Inc and Upsher-Smith Laboratories Inc have agreed to pay $60.2 million to resolve a lawsuit that said they entered into a deal to unlawfully delay the availability of generic versions of potassium supplement K-Dur.